215 related articles for article (PubMed ID: 12772594)
1. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR.
Nishimura M; Yaguti H; Yoshitsugu H; Naito S; Satoh T
Yakugaku Zasshi; 2003 May; 123(5):369-75. PubMed ID: 12772594
[TBL] [Abstract][Full Text] [Related]
2. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues.
Bièche I; Narjoz C; Asselah T; Vacher S; Marcellin P; Lidereau R; Beaune P; de Waziers I
Pharmacogenet Genomics; 2007 Sep; 17(9):731-42. PubMed ID: 17700362
[TBL] [Abstract][Full Text] [Related]
3. Comparative cytochrome P450 -1A1, -2A6, -2B6, -2C, -2D6, -2E1, -3A5 and -4B1 expressions in human larynx tissue analysed at mRNA level.
Sarikaya D; Bilgen C; Kamataki T; Topcu Z
Biopharm Drug Dispos; 2006 Nov; 27(8):353-9. PubMed ID: 16894644
[TBL] [Abstract][Full Text] [Related]
4. Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver.
Hakkola J; Pasanen M; Purkunen R; Saarikoski S; Pelkonen O; Mäenpää J; Rane A; Raunio H
Biochem Pharmacol; 1994 Jul; 48(1):59-64. PubMed ID: 8043031
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver.
Furukawa M; Nishimura M; Ogino D; Chiba R; Ikai I; Ueda N; Naito S; Kuribayashi S; Moustafa MA; Uchida T; Sawada H; Kamataki T; Funae Y; Fukumoto M
Cancer Sci; 2004 Jun; 95(6):520-9. PubMed ID: 15182434
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract.
Yang SP; Raner GM
Toxicol Appl Pharmacol; 2005 Jan; 202(2):140-50. PubMed ID: 15629189
[TBL] [Abstract][Full Text] [Related]
7. Quantitative RT-PCR measurement of human cytochrome P-450s: application to drug induction studies.
Rodríguez-Antona C; Jover R; Gómez-Lechón MJ; Castell JV
Arch Biochem Biophys; 2000 Apr; 376(1):109-16. PubMed ID: 10729196
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of cytochrome P450 mRNAs in patients with suspected liver diseases as assessed by reverse transcriptase-polymerase chain reaction.
Finnström N; Bjelfman C; Thörn M; Lööf L; Rane A
J Lab Clin Med; 1999 Aug; 134(2):133-40. PubMed ID: 10444026
[TBL] [Abstract][Full Text] [Related]
9. mRNA expression of multiple cytochrome p450 isozymes in four types of cultured skin cells.
Saeki M; Saito Y; Nagano M; Teshima R; Ozawa S; Sawada J
Int Arch Allergy Immunol; 2002 Apr; 127(4):333-6. PubMed ID: 12021553
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
Minoletti C; Dijols S; Dansette PM; Mansuy D
Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
[TBL] [Abstract][Full Text] [Related]
11. Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line.
Hukkanen J; Lassila A; Päivärinta K; Valanne S; Sarpo S; Hakkola J; Pelkonen O; Raunio H
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):360-6. PubMed ID: 10696073
[TBL] [Abstract][Full Text] [Related]
12. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.
Marill J; Cresteil T; Lanotte M; Chabot GG
Mol Pharmacol; 2000 Dec; 58(6):1341-8. PubMed ID: 11093772
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies.
Nishimura M; Naito S; Yokoi T
Drug Metab Pharmacokinet; 2004 Apr; 19(2):135-49. PubMed ID: 15499180
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
Westerink WM; Schoonen WG
Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
[TBL] [Abstract][Full Text] [Related]
15. Semi-automatic quantitative RT-PCR to measure CYP induction by drugs in human hepatocytes.
Pérez G; Tabares B; Jover R; Gómez-Lechón MJ; Castell JV
Toxicol In Vitro; 2003; 17(5-6):643-9. PubMed ID: 14599457
[TBL] [Abstract][Full Text] [Related]
16. Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine.
Olesen OV; Linnet K
Br J Clin Pharmacol; 2000 Dec; 50(6):563-71. PubMed ID: 11136295
[TBL] [Abstract][Full Text] [Related]
17. The mRNA expression of cytochrome P450 isoforms in human gastric tissue.
Canturk P; Caner V; Oruc N; Akarca US; Tepeli E; Cetin OG; Zencir S; Topcu Z
Hepatogastroenterology; 2010; 57(98):372-6. PubMed ID: 20583446
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cytochrome P450 expression in human oesophageal mucosa.
Lechevrel M; Casson AG; Wolf CR; Hardie LJ; Flinterman MB; Montesano R; Wild CP
Carcinogenesis; 1999 Feb; 20(2):243-8. PubMed ID: 10069460
[TBL] [Abstract][Full Text] [Related]
19. Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.
Xuan J; Chen S; Ning B; Tolleson WH; Guo L
Chem Biol Interact; 2016 Aug; 255():63-73. PubMed ID: 26477383
[TBL] [Abstract][Full Text] [Related]
20. Expression of xenobiotic-metabolizing cytochrome P450s in human pulmonary tissues.
Raunio H; Hakkola J; Hukkanen J; Pelkonen O; Edwards R; Boobis A; Anttila S
Arch Toxicol Suppl; 1998; 20():465-9. PubMed ID: 9442317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
